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INTRODUCTION

22
During dynamic exercise of increasing intensity, oxygen demand of the exercising muscle is 23 elevated, requiring a marked increase in skeletal muscle blood flow that is accomplished through small muscle mass exercise (37), suggesting that the skeletal muscle represents a "sleeping 29 giant" that must be under tonic restraint to avoid hypotension during intense, whole-body 30 exercise (41). Studies utilizing isolated arm and leg exercise modalities support this concept, 31 demonstrating a reduction in MAP when additional muscle mass is recruited at near maximal 32 exercise intensities, even in the face of drastic increases in sympathetic nervous system activity 33 (9, 37, 45, 52) . From these observations, the concept has been put forth that exercise-induced 34 metabolic vasodilation must be restrained to some degree in order to protect against precipitous 35 drops in MAP as the limit of cardiac output is reached.
36
Though sympathetic vasoconstriction is one of the primary regulators of vascular tone at 37 rest, the preponderance of data from studies in both animals and humans have demonstrated 38 substantial blunting of sympathetic vasoconstriction in the exercising skeletal muscle vasculature 39 (8, 12, 39, 43, 48, 53) . In the face of this loss of regional sympathetic control, it is likely that 40 non-adrenergic vasoconstrictor pathways may contribute significantly to the balance of skeletal 41 muscle blood flow and MAP during exercise. One such vasoconstrictor that may be relevant in 42 this regard is endothelin-1 (ET-1), the most potent endogenous vasoconstrictor (58). In the Therefore, the current study sought to determine the endogenous contribution of the ET A 60 receptor in the regulation of blood flow and MAP during increasing intensities of dynamic 61 exercise. We hypothesized that: 1) intra-arterial, local ET A receptor blockade would enhance 62 exercising skeletal muscle blood flow in an intensity-dependent manner and 2) the reduction in 
METHODS
66
Subjects
67
Eight young (24 ± 2 yrs), healthy subjects were enrolled in the present study. All subjects were 68 nonsmokers and were normally active. Subjects were not taking any prescription medication and 69 were free of overt cardiovascular disease, as indicated by a health history. Protocol approval and 70 written informed consent were obtained according to the University of Utah and the Salt Lake 
Protocols
76
Subjects reported to the UVRL at 0800 on the experimental day. After 30 min of supine rest, two 77 catheters (common femoral artery (CFA) and femoral vein) were placed using sterile technique,
78
as previously reported (1, 5, 57) . After catheter placement, subjects rested for ~30 min, and then 79 underwent the protocol as outlined in Figure 1 . Due to the duration of the study, subjects were 80 given 1/2 cup of corn flakes and 1/2 cup of skim milk 10 min before the start of the control 81 (saline) and the ET A recptor blockade (BQ-123) trials to prevent hypoglycemia (Figure 1 ). All 82 data collection took place with subjects in a semirecumbent position (60° reclined), and all 83 studies were performed in a thermoneutral environment.
84
Due to the long lasting effects of BQ-123, the drug administration portion of the protocol 85 always occurred after the saline portion of the protocol. Thus, to determine whether the observed 86 changes in leg blood flow and MAP were the consequence of an exercise ordering effect, rather 87 than the effect of the drug per se, subjects returned to the laboratory on a separate day to undergo an exercise time control study. For this visit, catheters were not placed, and no drugs were 89 administered. Apart from these differences, the timeline for this study was identical to the drug 90 infusion day, with the addition of leg blood flow measurements immediately before and after a 91 light meal to examine possible postprandial hemodynamic effects.
93
Drug Infusions
94
Thigh volumes were determined anthropometrically, and then used for the calculation of drug 95 dosing. A selective ET A receptor antagonist Clinalfa, 96 La¨ufelfingen, Switzerland) was prepared in normal saline (0.9% NaCl) and administered intra- Prior to use, in both conditions, the probe was calibrated using a block with known absorption 150 characteristics, to calculate the absorption and scattering coefficients. Prior to placement, the 151 lateral portion of the thigh was cleaned and double-sided adhesive tape was used to seat the and across exercise intensities. When a significant main effect was found (α < 0.05), the Holm-Sidak method was used for alpha adjustment and post hoc analysis. All group data are expressed 179 as mean ± standard error.
RESULTS
181
Subject Characteristics. Subject characteristics are presented in (Table 3) . 194 Additionally, a significant increase in the net ET-1 release and no significant changes in net 195 lactate release or pH were observed during BQ-123 infusion during exercise compared to the 196 saline trial ( Table 2) . It is tempting to speculate that this observed reduction in the exercise pressor reflex The importance of the ET-1 vasoconstrictor pathway in the cardiovascular response to 312 exercise may be of particular relevance in populations whose phenotype is associated with high 313 circulating levels of ET-1, such as hypertension (44), heart failure (6), chronic obstructive 314 pulmonary disease (13), and the elderly (31). All of these populations are associated with some 315 degree of exercise intolerance, which might be linked to the excessive increase in vascular tone 316 induced by the ET-1 vasoconstrictor pathway. This raises the interesting possibility of ET-1 as a 317 potential therapeutic target to improve skeletal muscle blood flow and ultimately exercise tolerance in these populations, though further studies are necessary to evaluate whether the 319 current observations can be extended to these patient groups. FIGURE 1: Experimental protocol. Arrows indicate points at which leg blood flow was recorded and arterial and venous blood samples obtained.
